Assembly Biosciences, Inc.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Assembly Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 40 | 38 | −2 |
| Shares | 14.2M | 12.1M | −2.14M (−15.0%) |
| Value | $18.4M | $10.1M | −$8.31M (−45.1%) |
New holders (3)
Institutions that held Assembly Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 38,303 | $32.2K | 0.00% |
| Virtu Financial LLC | 11,924 | $10.0K | 0.00% |
| Baker Avenue Asset Management, LP | 1,000 | $840 | 0.00% |
Sold out (5)
Institutions that held Assembly Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Deep Track Capital, LP | 1,833,437 | $2.38M |
| Connor, Clark & Lunn Investment Management Ltd. | 65,393 | $85.0K |
| Goldman Sachs Group Inc | 55,148 | $71.7K |
| Squarepoint Ops LLC | 10,485 | $13.6K |
| Bank of America Corp | 59 | $77 |